Mahamoud Sama Chérif1,2, Nut Koonrungsesomboon3,4, Diénaba Kassé5, Sékou Ditinn Cissé5, Saliou Bella Diallo5, Fatoumata Chérif6, Facély Camara5, Alpha Koné5, Eleonor Fundan Avenido3, Mandiou Diakité5, Mamadou Pathé Diallo5, Edouard Le Gall5,7, Mohamed Cissé5, Juntra Karbwang3, Kenji Hirayama8. 1. Faculty of Medicine, Gamal Abdel Nasser University of Conakry, Conakry, Guinea. msamafr@gmail.com. 2. Institute of Tropical Medicine (NEKKEN), Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan. msamafr@gmail.com. 3. Institute of Tropical Medicine (NEKKEN), Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan. 4. Department of Pharmacology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. 5. Faculty of Medicine, Gamal Abdel Nasser University of Conakry, Conakry, Guinea. 6. Ministry of Health and Public Hygiene, Conakry, Guinea. 7. Pôle Régional de Cancérologie Bretagne, Rennes, France. 8. Institute of Tropical Medicine (NEKKEN), Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan. hiraken@nagasaki-u.ac.jp.
Abstract
The most recent epidemic of Ebola virus disease (EVD) has resulted in more than 11,000 deaths in West Africa. It has threatened child health in the affected countries, including Guinea. This nationwide retrospective cohort study included all children under 20 years of age with laboratory-confirmed EVD in Guinea during the 2014-2015 Ebola outbreak for analysis. Of 8,448 children with probable or suspected EVD, 695 cases were laboratory-confirmed EVD. The overall case fatality rate (CFR) was 62.9%. Pediatric patients with younger age had a significantly higher rate of death (adjusted OR = 0.995; 95%CI = 0.990-1.000; p = 0.046), with the highest CFR of 82.9% in children aged less than 5 years. Fever (91%), fatigue (87%), and gastrointestinal signs and symptoms (70%) were common clinical features on admission of the pediatric patients, while bleeding signs were not occurring often (24%). None of clinical features and epidemiologic risk factors for Ebola were associated with mortality outcome in our cohort study. CONCLUSION: EVD is a major threat to child health, especially among children under 5 years of age. To date, none of demographic and clinical features, except younger age, have been consistently shown to affect mortality outcome in children infected with Ebola virus. What is Known: • The 2014-2015 West Africa Ebola epidemic is the largest and most widespread outbreak of Ebola virus disease (EVD) in history, with more than 11,000 deaths in Guinea, Liberia, and Sierra Leone. • During ongoing outbreak investigations, it is suggested that young children aged less than 5 years are particularly vulnerable and highly susceptible to death. What is New: • Demographic and clinical characteristics of the nationwide cohort of pediatric patients with laboratory-confirmed EVD in Guinea are reported. • The results confirm the high rate of death among EVD children under 5 years of age, while none of demographic and clinical features, except younger age, could serve as a predictor of mortality outcome in pediatric patients with EVD.
The most recent epidemic of Ebola virus disease (EVD) has resulted in more than 11,000 deaths in West Africa. It has threatened child health in the affected countries, including Guinea. This nationwide retrospective cohort study included all children under 20 years of age with laboratory-confirmed EVD in Guinea during the 2014-2015 Ebola outbreak for analysis. Of 8,448 children with probable or suspected EVD, 695 cases were laboratory-confirmed EVD. The overall case fatality rate (CFR) was 62.9%. Pediatric patients with younger age had a significantly higher rate of death (adjusted OR = 0.995; 95%CI = 0.990-1.000; p = 0.046), with the highest CFR of 82.9% in children aged less than 5 years. Fever (91%), fatigue (87%), and gastrointestinal signs and symptoms (70%) were common clinical features on admission of the pediatric patients, while bleeding signs were not occurring often (24%). None of clinical features and epidemiologic risk factors for Ebola were associated with mortality outcome in our cohort study. CONCLUSION: EVD is a major threat to child health, especially among children under 5 years of age. To date, none of demographic and clinical features, except younger age, have been consistently shown to affect mortality outcome in children infected with Ebola virus. What is Known: • The 2014-2015 West Africa Ebola epidemic is the largest and most widespread outbreak of Ebola virus disease (EVD) in history, with more than 11,000 deaths in Guinea, Liberia, and Sierra Leone. • During ongoing outbreak investigations, it is suggested that young children aged less than 5 years are particularly vulnerable and highly susceptible to death. What is New: • Demographic and clinical characteristics of the nationwide cohort of pediatric patients with laboratory-confirmed EVD in Guinea are reported. • The results confirm the high rate of death among EVD children under 5 years of age, while none of demographic and clinical features, except younger age, could serve as a predictor of mortality outcome in pediatric patients with EVD.
Authors: Carl O Eriksson; Timothy M Uyeki; Michael D Christian; Mary A King; Dana A V Braner; Robert K Kanter; Niranjan Kissoon Journal: Pediatr Crit Care Med Date: 2015-02 Impact factor: 3.624
Authors: M A Trad; W Naughton; A Yeung; L Mazlin; M O'sullivan; N Gilroy; D A Fisher; R L Stuart Journal: J Clin Virol Date: 2016-11-11 Impact factor: 3.168
Authors: Junerlyn Agua-Agum; Archchun Ariyarajah; Bruce Aylward; Isobel M Blake; Richard Brennan; Anne Cori; Christl A Donnelly; Ilaria Dorigatti; Christopher Dye; Tim Eckmanns; Neil M Ferguson; Pierre Formenty; Christophe Fraser; Erika Garcia; Tini Garske; Wes Hinsley; David Holmes; Stéphane Hugonnet; Swathi Iyengar; Thibaut Jombart; Ravi Krishnan; Sascha Meijers; Harriet L Mills; Yasmine Mohamed; Gemma Nedjati-Gilani; Emily Newton; Pierre Nouvellet; Louise Pelletier; Devin Perkins; Steven Riley; Maria Sagrado; Johannes Schnitzler; Dirk Schumacher; Anita Shah; Maria D Van Kerkhove; Olivia Varsaneux; Niluka Wijekoon Kannangarage Journal: N Engl J Med Date: 2014-12-24 Impact factor: 91.245
Authors: Anita K McElroy; Bobbie R Erickson; Timothy D Flietstra; Pierre E Rollin; Stuart T Nichol; Jonathan S Towner; Christina F Spiropoulou Journal: Emerg Infect Dis Date: 2014-10 Impact factor: 6.883
Authors: J Y Wong; W Zhang; D Kargbo; U Haque; W Hu; P Wu; A Kamara; Y Chen; B Kargbo; G E Glass; R Yang; B J Cowling; C Liu Journal: Epidemiol Infect Date: 2016-05 Impact factor: 4.434
Authors: Bruce Aylward; Philippe Barboza; Luke Bawo; Eric Bertherat; Pepe Bilivogui; Isobel Blake; Rick Brennan; Sylvie Briand; Jethro Magwati Chakauya; Kennedy Chitala; Roland M Conteh; Anne Cori; Alice Croisier; Jean-Marie Dangou; Boubacar Diallo; Christl A Donnelly; Christopher Dye; Tim Eckmanns; Neil M Ferguson; Pierre Formenty; Caroline Fuhrer; Keiji Fukuda; Tini Garske; Alex Gasasira; Stephen Gbanyan; Peter Graaff; Emmanuel Heleze; Amara Jambai; Thibaut Jombart; Francis Kasolo; Albert Mbule Kadiobo; Sakoba Keita; Daniel Kertesz; Moussa Koné; Chris Lane; Jered Markoff; Moses Massaquoi; Harriet Mills; John Mike Mulba; Emmanuel Musa; Joel Myhre; Abdusalam Nasidi; Eric Nilles; Pierre Nouvellet; Deo Nshimirimana; Isabelle Nuttall; Tolbert Nyenswah; Olushayo Olu; Scott Pendergast; William Perea; Jonathan Polonsky; Steven Riley; Olivier Ronveaux; Keita Sakoba; Ravi Santhana Gopala Krishnan; Mikiko Senga; Faisal Shuaib; Maria D Van Kerkhove; Rui Vaz; Niluka Wijekoon Kannangarage; Zabulon Yoti Journal: N Engl J Med Date: 2014-09-22 Impact factor: 91.245
Authors: Alicia E Genisca; Tzu-Chun Chu; Lawrence Huang; Monique Gainey; Moyinoluwa Adeniji; Eta N Mbong; Stephen B Kennedy; Razia Laghari; Fiston Nganga; Rigo F Muhayangabo; Himanshu Vaishnav; Shiromi M Perera; Andrés Colubri; Adam C Levine; Ian C Michelow Journal: Emerg Infect Dis Date: 2022-06 Impact factor: 16.126
Authors: Alicia E Genisca; Kelsey Butler; Monique Gainey; Tzu-Chun Chu; Lawrence Huang; Eta N Mbong; Stephen B Kennedy; Razia Laghari; Fiston Nganga; Rigobert F Muhayangabo; Himanshu Vaishnav; Shiromi M Perera; Moyinoluwa Adeniji; Adam C Levine; Ian C Michelow; Andrés Colubri Journal: PLoS Negl Trop Dis Date: 2022-10-12
Authors: Shevin T Jacob; Ian Crozier; William A Fischer; Angela Hewlett; Colleen S Kraft; Marc-Antoine de La Vega; Moses J Soka; Victoria Wahl; Anthony Griffiths; Laura Bollinger; Jens H Kuhn Journal: Nat Rev Dis Primers Date: 2020-02-20 Impact factor: 52.329